-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy To Target HER-2 For Oncology in Ductal Carcinoma In Situ
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cellular Immunotherapy To Target HER-2 For Oncology in Ductal Carcinoma In Situ report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cellular Immunotherapy To Target...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy To Target HER-2 For Oncology in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cellular Immunotherapy To Target HER-2 For Oncology in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy To Target HER-2 For Oncology in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cellular Immunotherapy To Target HER-2 For Oncology in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – DEN-181 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DEN-181 in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DEN-181 in Rheumatoid Arthritis Drug Details: DEN-181 (Rheumavax) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MesoCancerVac in Malignant Mesothelioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MesoCancerVac in Malignant Mesothelioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MesoCancerVac in Malignant Mesothelioma Drug Details: MesoCancerVac is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AL-002 in Dementia Associated With Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AL-002 in Dementia Associated With Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AL-002 in Dementia Associated With Alzheimer's Disease Drug Details:...
-
Product Insights
NewTotal Artificial Heart Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
A Total Artificial Heart is a prosthetic device that is implanted into the body to replace the biological heart. GlobalData's Medical Devices sector report, “Total Artificial Heart Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Total Artificial Heart pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Total Artificial Heart report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MesoCancerVac in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MesoCancerVac in Metastatic Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MesoCancerVac in Metastatic Pancreatic Cancer Drug Details: MesoCancerVac is under development...
-
Product Insights
NewElectrophysiology Ablation Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Electrophysiology Ablation Catheters Pipeline Market Report Overview Electrophysiology ablation is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complication and recurrence. The electrophysiology ablation catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and...
-
Sector Analysis
Implantable Cardioverter Defibrillators (ICD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Implantable Cardioverter Defibrillators Market Report Overview The implantable cardioverter defibrillators market size was $2.76 billion in 2023. The market is expected to register a modest CAGR of more than 2% during 2023-2033. An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia to restore the heart’s natural rhythm. Implantable Cardioverter Defibrillators Market Outlook, 2023-2033 ($ Billion)  Buy the Full Report for More Insights into the Implantable Cardioverter...